U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT06836180) titled 'An Exploratory Study of Near-infrared Light Therapy for Mild to Moderate Alzheimer's Disease' on Jan. 12.
Brief Summary: This is an exploratory clinical study to evaluate the efficacy and safety of near-infrared light therapeutics in the treatment of mild to moderate Alzheimer's disease.
Study Start Date: Feb. 23
Study Type: INTERVENTIONAL
Condition:
Alzheimer Disease
Intervention:
DEVICE: Near infrared light therapy
Once a day, once 30 minutes of near-infrared light treatment, 6 times a week for 96 weeks
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Xuanwu Hospital, Beijing
Disclaimer: Curated by HT Syndication....